CLINICAL ROLE -
4 Activities Pharmacists Should Try This Summer
Summer is here, and pharmacists may be considering trying new and exciting activities.
Read More
Blood Cancer Treatment Gets FDA Nod
The approval is based on multiple clinical trials, and provides patients with a subcutaneous option for rituximab that shortens the treatment time to 5 to 7 minutes compared with intravenous infusion.
FDA Approves C1 Esterase Inhibitor to Treat Genetic Disease
Rituximab Plus Hyaluronidase Combination Approved to Treat Leukemia, Lymphomas
Subcutaneous administration of Rituxan Hycela shortens treatment length to only 5 to 7 minutes.
Rituxan Hycela Combination Approved for Blood Cancers
Rituximab and hyaluronidase human approved for the treatment of adults with follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.
Pharmacy Outlook for Independent Pharmacies & Collaborative Practice
Forward-thinking pharmacies can capitalize on the rise of value-based care.
Senate Legislation Targets Prescription Drug Cost Increases
The Stop Price Gouging Act would hold manufacturers accountable for unjustifiable drug price increases.
Medicaid Patients Hit Hard by Opioid Epidemic
Opioid use among Medicaid-insured women 13% higher than the general population.
Noninvasive Imaging Technique Could Help Diagnose, Monitor HIV-Associated Sensory Neuropathy
Patients with HIV-associated sensory neuropathy have a decrease in corneal nerve fiber density and an increase in corneal nerve tortuosity.
Similarities Among Human, Dog Mammary Tumors May Boost Cancer Research
Could household pets be the key to treating breast carcinoma?
Latest Developments in Treating Deadly Brain Tumor in Children
Restoring a tumor suppressing gene offers a promising therapeutic target for diffuse intrinsic pontine glioma.
Glucose Could Play a Role in Cancer Treatment
Glucose-starved immune cells elicit stronger response to cancer cells.
Combination BRAF, MEK Inhibitor Improves Melanoma Survival
Dabrafenib + trametinib treats patients with unresectable or metastatic melanoma who have a BRAF V600 mutation.
Opioid Epidemic Ravages Europe
Opioids may have played a role in up to 79% of deaths in Europe in 2015.
Red Onion Extracts Exhibit Anti-Cancer Properties
Onions contain one of the highest concentrations of quercetin, a flavonoid extract with anti-proliferative effects.
Trending News Today: Another Payer Withdraws from ACA Marketplace
Top news of the day from across the health care landscape.
Tafinlar-Mekinist Combination Improves Overall Survival in Melanoma
BRAF and MEK inhibitors benefit patients with BRAF V600 mutation-positive melanoma.
Trending News Today: Majority of Americans Feel AHCA Will Harm Low-Income Individuals
Top news of the day from across the healthcare landscape.
Experiential Interprofessional Education Programs Can Improve Diabetes Care
Eighty percent of patients with diabetes have uncontrolled blood sugars, blood pressures, or cholesterol.
Experiential Interprofessional Education Programs: A Missing Link to Better Diabetes Care
The Journal of Continuing Education in the Health Professions has published a study that assessed the effect of interprofessional education (IPE) on the quality of diabetes care.
Two Investigational Drugs to Treat Psoriatic Arthritis on the Horizon
Tofacitinib and Guselkumab show promise in patients with PsA.
CMS Proposes Changes to Quality Payment Program
Proposed changes to the Quality Payment Program would increase flexibility for clinicians.
Shell Breast Cancer Charity Pocketed Donations
Breast Cancer Survivors Foundation settled to pay $350,000 to legitimate breast cancer charities.
New Drug Application Submitted for Triple-Therapy HIV Drug
Investigational HIV combination drug may improve virologic suppression.
Cannabis Chewing Gum Clinical Trials Secure Funding to Treat Irritable Bowel Syndrome, MS
Cannabinoid treatment may alleviate some symptoms of multiple sclerosis and IBS, in addition to chemotherapy-induced nausea.
EMDAC Panel: Liraglutide Linked with Reduced CVD Risk in T2DM Patients
The discussions at the Advisory Committee meeting were based on data from the LEADER trial.
Variations in HCV Strains Impacts Efficacy of NS5A Inhibitors
How NS5A inhibitors block hepatitis C virus replication impacts treatment outcomes.
Cardiovascular Drugs Should be Dosed Differently by Gender
Women experience more severe adverse events related to cardiovascular drugs.
Rate of Cancer Diagnoses Higher Among More Affluent Communities
Overutilization of care can produce disparities between high- and low-income counties.
Rheumatoid Arthritis Vaccine Candidate Suppresses Disease Progression in Mice
Novel vaccine modulates T cell responses in RA.